InvestorsHub Logo
Post# of 252865
Next 10
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

Re: jq1234 post# 120027

Sunday, 05/15/2011 3:23:02 PM

Sunday, May 15, 2011 3:23:02 PM

Post# of 252865

I wouldn't say switchover back and forth is big concern.



The theoretical issue is that you somehow engender cross-immunogenicity when switching back and forth between multiple different generics. With complex proteins that are all a bit different from each other it is a potential concern.

Peter
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.